Abstract
The existence of naturally occurring regulatory T cells in normal hosts and their pivotal role in maintaining both auto- and allo-tolerance have direct implications on the therapy of autoimmune disorders and for achieving immunosuppression-free allotransplantation. Among the various forms of regulatory T cells described, CD4+CD25+ T cells have emerged as one of the most potent tolerogenic subsets. In this review, we discuss the molecular basis of development and function of these regulatory T cells and their potential role in the context of chronic lung allograft rejection.
Original language | English (US) |
---|---|
Pages (from-to) | 195-212 |
Number of pages | 18 |
Journal | Immunologic Research |
Volume | 33 |
Issue number | 3 |
DOIs | |
State | Published - Dec 2005 |
Funding
This work was supported by NIH HL56543 and HL66452 (T.M.). R.C.F. is a recipient of an ISHLT Research Fellowship Award and an AST Fellowship.
Keywords
- Adaptive immune response
- Antigen presentation
- Infectious tolerance
- Lung transplantation
- Regulatory cells
- T cells
- Transplantation tolerance
ASJC Scopus subject areas
- Immunology